<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/2400BE3D-876A-41C9-8178-94887A51CA1C"><gtr:id>2400BE3D-876A-41C9-8178-94887A51CA1C</gtr:id><gtr:name>University Hospitals Birmingham NHS Foundation Trust</gtr:name><gtr:address><gtr:line1>Metchley Park Road</gtr:line1><gtr:city>Birmingham</gtr:city><gtr:postCode>B15 2PR</gtr:postCode><gtr:region>West Midlands</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/864A9845-BA2F-4BF8-AD6D-91B724CF5991"><gtr:id>864A9845-BA2F-4BF8-AD6D-91B724CF5991</gtr:id><gtr:name>Royal Infirmary of Edinburgh</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/AE6EAB1A-CC2F-4FDB-A57F-41E76D78ACAB"><gtr:id>AE6EAB1A-CC2F-4FDB-A57F-41E76D78ACAB</gtr:id><gtr:name>Oxford University Hospitals NHS Trust</gtr:name><gtr:address><gtr:line1>Churchill Site</gtr:line1><gtr:line2>Old Road</gtr:line2><gtr:line3>Headington</gtr:line3><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX3 7LJ</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/4A348A76-B2D0-4DDD-804A-CE735A6D3798"><gtr:id>4A348A76-B2D0-4DDD-804A-CE735A6D3798</gtr:id><gtr:name>University of Bristol</gtr:name><gtr:address><gtr:line1>Senate House</gtr:line1><gtr:line4>Bristol</gtr:line4><gtr:line5>Avon</gtr:line5><gtr:postCode>BS8 1TH</gtr:postCode><gtr:region>South West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/7A601437-2EFC-42F2-9E23-3B4D475CF80D"><gtr:id>7A601437-2EFC-42F2-9E23-3B4D475CF80D</gtr:id><gtr:name>Gloucestershire Royal Hospital</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/7035AE5D-F006-4762-9959-D965363291F6"><gtr:id>7035AE5D-F006-4762-9959-D965363291F6</gtr:id><gtr:name>Merck</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/B525E1E8-5E37-4C23-B66D-6E6D79AC783A"><gtr:id>B525E1E8-5E37-4C23-B66D-6E6D79AC783A</gtr:id><gtr:name>Royal Devon and Exeter NHS Foundation Trust</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/8FF77491-6D8F-46B3-A501-502C02F1142F"><gtr:id>8FF77491-6D8F-46B3-A501-502C02F1142F</gtr:id><gtr:name>Bristol Royal Infirmary</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/064A41A2-AC2E-4ACC-A55B-D38D3434BD6A"><gtr:id>064A41A2-AC2E-4ACC-A55B-D38D3434BD6A</gtr:id><gtr:name>Queen's Medical Centre</gtr:name><gtr:address><gtr:line1>Queen's Medical Centre</gtr:line1><gtr:line2>Derby Rd</gtr:line2><gtr:postCode>NG7 2UH</gtr:postCode><gtr:region>East Midlands</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/D1170893-AEB7-4F2F-AA16-67D6E09D2608"><gtr:id>D1170893-AEB7-4F2F-AA16-67D6E09D2608</gtr:id><gtr:name>Glasgow Royal Infirmary</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/696A0A2F-736F-4546-B0F4-F347F0F8488E"><gtr:id>696A0A2F-736F-4546-B0F4-F347F0F8488E</gtr:id><gtr:name>Freeman Hospital</gtr:name><gtr:address><gtr:line1>Liver and Renal Transplant Unit
Freeman Hospital
Freeman Road
High Heaton</gtr:line1><gtr:city>Newcastle Upon Tyne</gtr:city><gtr:postCode>NE7 7DN</gtr:postCode><gtr:region>North East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/4E55B119-02E7-43F3-9B39-DD48A6511372"><gtr:id>4E55B119-02E7-43F3-9B39-DD48A6511372</gtr:id><gtr:name>Addenbrooke's Hospital</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/DD1F1403-9928-4563-8E48-326ACF87C706"><gtr:id>DD1F1403-9928-4563-8E48-326ACF87C706</gtr:id><gtr:name>University Hospital of Wales</gtr:name></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/7369E051-ECFC-4808-A044-651879C318D1"><gtr:id>7369E051-ECFC-4808-A044-651879C318D1</gtr:id><gtr:name>MRC Cancer Cell Unit</gtr:name><gtr:address><gtr:line1>Hills Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:line5>Cambridgeshire</gtr:line5><gtr:postCode>CB2 2XZ</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/7369E051-ECFC-4808-A044-651879C318D1"><gtr:id>7369E051-ECFC-4808-A044-651879C318D1</gtr:id><gtr:name>MRC Cancer Cell Unit</gtr:name><gtr:address><gtr:line1>Hills Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:line5>Cambridgeshire</gtr:line5><gtr:postCode>CB2 2XZ</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/2400BE3D-876A-41C9-8178-94887A51CA1C"><gtr:id>2400BE3D-876A-41C9-8178-94887A51CA1C</gtr:id><gtr:name>University Hospitals Birmingham NHS Foundation Trust</gtr:name><gtr:address><gtr:line1>Metchley Park Road</gtr:line1><gtr:city>Birmingham</gtr:city><gtr:postCode>B15 2PR</gtr:postCode><gtr:region>West Midlands</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/864A9845-BA2F-4BF8-AD6D-91B724CF5991"><gtr:id>864A9845-BA2F-4BF8-AD6D-91B724CF5991</gtr:id><gtr:name>Royal Infirmary of Edinburgh</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/AE6EAB1A-CC2F-4FDB-A57F-41E76D78ACAB"><gtr:id>AE6EAB1A-CC2F-4FDB-A57F-41E76D78ACAB</gtr:id><gtr:name>Oxford University Hospitals NHS Trust</gtr:name><gtr:address><gtr:line1>Churchill Site</gtr:line1><gtr:line2>Old Road</gtr:line2><gtr:line3>Headington</gtr:line3><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX3 7LJ</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/4A348A76-B2D0-4DDD-804A-CE735A6D3798"><gtr:id>4A348A76-B2D0-4DDD-804A-CE735A6D3798</gtr:id><gtr:name>University of Bristol</gtr:name><gtr:address><gtr:line1>Senate House</gtr:line1><gtr:line4>Bristol</gtr:line4><gtr:line5>Avon</gtr:line5><gtr:postCode>BS8 1TH</gtr:postCode><gtr:region>South West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/7A601437-2EFC-42F2-9E23-3B4D475CF80D"><gtr:id>7A601437-2EFC-42F2-9E23-3B4D475CF80D</gtr:id><gtr:name>Gloucestershire Royal Hospital</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/7035AE5D-F006-4762-9959-D965363291F6"><gtr:id>7035AE5D-F006-4762-9959-D965363291F6</gtr:id><gtr:name>Merck</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/B525E1E8-5E37-4C23-B66D-6E6D79AC783A"><gtr:id>B525E1E8-5E37-4C23-B66D-6E6D79AC783A</gtr:id><gtr:name>Royal Devon and Exeter NHS Foundation Trust</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/8FF77491-6D8F-46B3-A501-502C02F1142F"><gtr:id>8FF77491-6D8F-46B3-A501-502C02F1142F</gtr:id><gtr:name>Bristol Royal Infirmary</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/064A41A2-AC2E-4ACC-A55B-D38D3434BD6A"><gtr:id>064A41A2-AC2E-4ACC-A55B-D38D3434BD6A</gtr:id><gtr:name>Queen's Medical Centre</gtr:name><gtr:address><gtr:line1>Queen's Medical Centre</gtr:line1><gtr:line2>Derby Rd</gtr:line2><gtr:postCode>NG7 2UH</gtr:postCode><gtr:region>East Midlands</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/D1170893-AEB7-4F2F-AA16-67D6E09D2608"><gtr:id>D1170893-AEB7-4F2F-AA16-67D6E09D2608</gtr:id><gtr:name>Glasgow Royal Infirmary</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/696A0A2F-736F-4546-B0F4-F347F0F8488E"><gtr:id>696A0A2F-736F-4546-B0F4-F347F0F8488E</gtr:id><gtr:name>Freeman Hospital</gtr:name><gtr:address><gtr:line1>Liver and Renal Transplant Unit
Freeman Hospital
Freeman Road
High Heaton</gtr:line1><gtr:city>Newcastle Upon Tyne</gtr:city><gtr:postCode>NE7 7DN</gtr:postCode><gtr:region>North East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/4E55B119-02E7-43F3-9B39-DD48A6511372"><gtr:id>4E55B119-02E7-43F3-9B39-DD48A6511372</gtr:id><gtr:name>Addenbrooke's Hospital</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/DD1F1403-9928-4563-8E48-326ACF87C706"><gtr:id>DD1F1403-9928-4563-8E48-326ACF87C706</gtr:id><gtr:name>University Hospital of Wales</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/7EA7E476-F8CD-4A75-9746-0058BEC86C92"><gtr:id>7EA7E476-F8CD-4A75-9746-0058BEC86C92</gtr:id><gtr:firstName>Rebecca</gtr:firstName><gtr:surname>Fitzgerald</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=MC_U105365007"><gtr:id>46C6070B-9A51-41CF-BCCA-AC1F583B11BF</gtr:id><gtr:title>Barretts metaplasia and associated carcinogenesis</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Intramural</gtr:grantCategory><gtr:grantReference>MC_U105365007</gtr:grantReference><gtr:abstractText>A type of oesophageal or gullet cancer, called adenocarcinoma, is rapidly increasing in the western world. Most patients do not seek medical attention until they develop swallowing difficulties and by then the cancer is usually advanced with a 5-year survival of &amp;lt;20%. However, if the cancer is detected early then the survival rate can be improved to &amp;gt;80%. These cancers usually develop as a complication of a condition called Barretts oesophagus which occurs in approximately 10% of those with heartburn symptoms. However, most people in the population with Barretts are not diagnosed and most will not develop cancer. Therefore research is needed to identify the patients at greatest risk for oesophageal cancer. |The specific issues being addressed are:| Can we identify high-risk groups for the development of Barretts oesophagus and oesophageal adenocarcinoma?| Can we understand the development and progression of oesophageal cancer at a molecular level so that we can develop effective clinical tools for patient management? |To do this research we work closely with the clinical service at Addenbrookes Hospital. Patients have the opportunity to take part in research by providing us with essential clinical specimens.|</gtr:abstractText><gtr:technicalSummary>We conduct translational research on oesophageal cancer and the precursor lesion called Barretts oesophagus. This is important because the incidence of oesophageal cancer is increasing rapidly and the outcomes are dismal. The diagnostic tools and treatments available are limited, but the MRC Cancer Medicine Unit offers a unique opportunity for beneficial research because of its proximity to the clinical environment and its opportunities for scientific collaboration. Recent achievements include development of a non-endoscopic device coupled to an immunocytological assay which has gone all the way from conception to a clinical trial. Our over-riding objective for the future is to understand the molecular and cellular drivers for the development and progression of Barretts oesophagus and in so doing to provide tools for early diagnosis, accurate prognostication and therapy which can be applied to clinical practice.</gtr:technicalSummary><gtr:fund><gtr:end>2013-09-30</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2002-12-01</gtr:start><gtr:type>EXPENDITURE_ACTUAL</gtr:type><gtr:valuePounds>5036063</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Bristol Royal Infirmary</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>OCCAMS (Oesophageal Cancer Clinical and Molecular Staging)</gtr:description><gtr:id>196CF91B-AF4D-4855-9535-F95E4842DF82</gtr:id><gtr:impact>PMID: 19526624 
PMID: 20621683</gtr:impact><gtr:outcomeId>10993C9ABB4-2</gtr:outcomeId><gtr:partnerContribution>Shared dataShared dataShared dataShared dataShared dataShared dataShared dataShared dataShared dataShared data</gtr:partnerContribution><gtr:piContribution>We set up this UK multicentre collaboration which currently includes 10 centres from around the UK</gtr:piContribution><gtr:sector>Hospitals</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Merck</gtr:collaboratingOrganisation><gtr:country>Germany, Federal Republic of</gtr:country><gtr:description>prognostic gene signtaures in oesophageal cancer</gtr:description><gtr:id>42888229-B5C9-479A-9C6F-BD33EDE9AEFD</gtr:id><gtr:impact>This profiling project would not have been affordable within the programme grant. The data has been invaluable for developing prognostic alogorithm which are now at the validation stage.</gtr:impact><gtr:outcomeId>E4B76902070-1</gtr:outcomeId><gtr:partnerContribution>Research data</gtr:partnerContribution><gtr:piContribution>Research on data provided</gtr:piContribution><gtr:sector>Private</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University Hospital of Wales</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>OCCAMS (Oesophageal Cancer Clinical and Molecular Staging)</gtr:description><gtr:id>512C1A61-725B-456E-85F9-014B33133FF7</gtr:id><gtr:impact>PMID: 19526624 
PMID: 20621683</gtr:impact><gtr:outcomeId>10993C9ABB4-8</gtr:outcomeId><gtr:partnerContribution>Shared dataShared dataShared dataShared dataShared dataShared dataShared dataShared dataShared dataShared data</gtr:partnerContribution><gtr:piContribution>We set up this UK multicentre collaboration which currently includes 10 centres from around the UK</gtr:piContribution><gtr:sector>Hospitals</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Addenbrooke's Hospital</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Barrett's oEsophagus Screening Trial 2 (BEST2)</gtr:description><gtr:id>25BA02C9-1BB9-46F4-8174-96994F444D2D</gtr:id><gtr:impact>Still on-going.</gtr:impact><gtr:outcomeId>XUJT5ZoZKca-1</gtr:outcomeId><gtr:partnerContribution>Multicentre, Case-control Study.</gtr:partnerContribution><gtr:piContribution>Evaluation of a Non-Endoscopic Immunocytological Device (Cytosponge) for Barrett's Esophagus Screening in a Case-Control Study (BEST2).</gtr:piContribution><gtr:sector>Hospitals</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University Hospitals Birmingham NHS Foundation Trust</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>OCCAMS (Oesophageal Cancer Clinical and Molecular Staging)</gtr:description><gtr:id>14D69F08-9942-48F3-8E0D-0E4531FAB30F</gtr:id><gtr:impact>PMID: 19526624 
PMID: 20621683</gtr:impact><gtr:outcomeId>10993C9ABB4-1</gtr:outcomeId><gtr:partnerContribution>Shared dataShared dataShared dataShared dataShared dataShared dataShared dataShared dataShared dataShared data</gtr:partnerContribution><gtr:piContribution>We set up this UK multicentre collaboration which currently includes 10 centres from around the UK</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Gloucestershire Royal Hospital</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>OCCAMS (Oesophageal Cancer Clinical and Molecular Staging)</gtr:description><gtr:id>76A61D57-B60E-4317-B3F7-444F7B783B22</gtr:id><gtr:impact>PMID: 19526624 
PMID: 20621683</gtr:impact><gtr:outcomeId>10993C9ABB4-9</gtr:outcomeId><gtr:partnerContribution>Shared dataShared dataShared dataShared dataShared dataShared dataShared dataShared dataShared dataShared data</gtr:partnerContribution><gtr:piContribution>We set up this UK multicentre collaboration which currently includes 10 centres from around the UK</gtr:piContribution><gtr:sector>Hospitals</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Queen's Medical Centre</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Barrett's oEsophagus Screening Trial 2 (BEST2)</gtr:description><gtr:id>CEB4410D-D9CB-4FFC-8D4D-2E69A75185B8</gtr:id><gtr:impact>Still on-going.</gtr:impact><gtr:outcomeId>XUJT5ZoZKca-2</gtr:outcomeId><gtr:partnerContribution>Multicentre, Case-control Study.</gtr:partnerContribution><gtr:piContribution>Evaluation of a Non-Endoscopic Immunocytological Device (Cytosponge) for Barrett's Esophagus Screening in a Case-Control Study (BEST2).</gtr:piContribution><gtr:sector>Hospitals</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Glasgow Royal Infirmary</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>OCCAMS (Oesophageal Cancer Clinical and Molecular Staging)</gtr:description><gtr:id>032626B1-E874-4148-92F8-009555891847</gtr:id><gtr:impact>PMID: 19526624 
PMID: 20621683</gtr:impact><gtr:outcomeId>10993C9ABB4-5</gtr:outcomeId><gtr:partnerContribution>Shared dataShared dataShared dataShared dataShared dataShared dataShared dataShared dataShared dataShared data</gtr:partnerContribution><gtr:piContribution>We set up this UK multicentre collaboration which currently includes 10 centres from around the UK</gtr:piContribution><gtr:sector>Hospitals</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Bristol</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>School of Clinical Sciences</gtr:department><gtr:description>OCCAMS (Oesophageal Cancer Clinical and Molecular Staging)</gtr:description><gtr:id>ACB77262-EB0E-49B0-AC3E-EF1FEFF2F922</gtr:id><gtr:impact>PMID: 19526624 
PMID: 20621683</gtr:impact><gtr:outcomeId>10993C9ABB4-6</gtr:outcomeId><gtr:partnerContribution>Shared dataShared dataShared dataShared dataShared dataShared dataShared dataShared dataShared dataShared data</gtr:partnerContribution><gtr:piContribution>We set up this UK multicentre collaboration which currently includes 10 centres from around the UK</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Freeman Hospital</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Barrett's oEsophagus Screening Trial 2 (BEST2)</gtr:description><gtr:id>271E57E8-F20C-494C-A503-61322F04DBEB</gtr:id><gtr:impact>Still on-going.</gtr:impact><gtr:outcomeId>XUJT5ZoZKca-4</gtr:outcomeId><gtr:partnerContribution>Multicentre, Case-control Study.</gtr:partnerContribution><gtr:piContribution>Evaluation of a Non-Endoscopic Immunocytological Device (Cytosponge) for Barrett's Esophagus Screening in a Case-Control Study (BEST2).</gtr:piContribution><gtr:sector>Hospitals</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Oxford University Hospitals NHS Foundation Trust</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>OCCAMS (Oesophageal Cancer Clinical and Molecular Staging)</gtr:description><gtr:id>CDFA83A4-58C7-4619-8F02-8793ED4F7C1A</gtr:id><gtr:impact>PMID: 19526624 
PMID: 20621683</gtr:impact><gtr:outcomeId>10993C9ABB4-7</gtr:outcomeId><gtr:partnerContribution>Shared dataShared dataShared dataShared dataShared dataShared dataShared dataShared dataShared dataShared data</gtr:partnerContribution><gtr:piContribution>We set up this UK multicentre collaboration which currently includes 10 centres from around the UK</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Royal Infirmary of Edinburgh</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>OCCAMS (Oesophageal Cancer Clinical and Molecular Staging)</gtr:description><gtr:id>41995F4B-525D-47A9-8AEC-022A3C812CF0</gtr:id><gtr:impact>PMID: 19526624 
PMID: 20621683</gtr:impact><gtr:outcomeId>10993C9ABB4-3</gtr:outcomeId><gtr:partnerContribution>Shared dataShared dataShared dataShared dataShared dataShared dataShared dataShared dataShared dataShared data</gtr:partnerContribution><gtr:piContribution>We set up this UK multicentre collaboration which currently includes 10 centres from around the UK</gtr:piContribution><gtr:sector>Hospitals</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Royal Devon and Exeter NHS Foundation Trust</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>OCCAMS (Oesophageal Cancer Clinical and Molecular Staging)</gtr:description><gtr:id>529B6F11-A21C-457B-A4FE-E04AFAF28647</gtr:id><gtr:impact>PMID: 19526624 
PMID: 20621683</gtr:impact><gtr:outcomeId>10993C9ABB4-4</gtr:outcomeId><gtr:partnerContribution>Shared dataShared dataShared dataShared dataShared dataShared dataShared dataShared dataShared dataShared data</gtr:partnerContribution><gtr:piContribution>We set up this UK multicentre collaboration which currently includes 10 centres from around the UK</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>UCL Cancer Institute</gtr:department><gtr:description>Barrett's oEsophagus Screening Trial 2 (BEST2)</gtr:description><gtr:id>D25445D6-4130-43BF-81CC-F866AFAF0C0F</gtr:id><gtr:impact>Still on-going.</gtr:impact><gtr:outcomeId>XUJT5ZoZKca-3</gtr:outcomeId><gtr:partnerContribution>Multicentre, Case-control Study.</gtr:partnerContribution><gtr:piContribution>Evaluation of a Non-Endoscopic Immunocytological Device (Cytosponge) for Barrett's Esophagus Screening in a Case-Control Study (BEST2).</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Addenbrooke's Hospital</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>OCCAMS (Oesophageal Cancer Clinical and Molecular Staging)</gtr:description><gtr:id>1D7CB13D-78DA-4837-A409-D3D23E31EFFD</gtr:id><gtr:impact>PMID: 19526624 
PMID: 20621683</gtr:impact><gtr:outcomeId>10993C9ABB4-10</gtr:outcomeId><gtr:partnerContribution>Shared dataShared dataShared dataShared dataShared dataShared dataShared dataShared dataShared dataShared data</gtr:partnerContribution><gtr:piContribution>We set up this UK multicentre collaboration which currently includes 10 centres from around the UK</gtr:piContribution><gtr:sector>Hospitals</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Cambridge Science Festival Schools Outreach Roadshow</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>BEA61DCB-626A-4532-87FD-07BBE66C6CB5</gtr:id><gtr:impact>Around 300 pupils aged between 8-11 attended roadshow events which consisted of hands-on activities and talks about the science of digestion and related topics.

Increased awareness of biological processes, cancer research and the work of the unit.</gtr:impact><gtr:outcomeId>KQu1J1kPFTg</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2008,2009,2010,2011,2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Schools Roadshow</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>2FA1D5EB-E5A7-4D14-99D6-0DA7E37C8BA6</gtr:id><gtr:impact>&amp;quot;Gurgling guts&amp;quot; roadshow event on human body, digestion and disease taken to three schools in wider Cambridgeshire area (with limited access to extra science resources). Aimed at keystage 2 pupils. 
In following years event held in central location to audience of c.100 school children from the wider Cambridge area.

Increased understanding of science in this area.</gtr:impact><gtr:outcomeId>5949D755F0D</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2008,2009,2010,2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>BBC News story- quote 2013</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>BA75ABD2-EA04-4482-9D0B-A5B892F3FBD7</gtr:id><gtr:impact>Quoted in BBC news article on oesophageal cancer and diagnosis.

Increase in profile for research and awareness of the disease.</gtr:impact><gtr:outcomeId>ZkkeTzT3y4W</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>http://www.bbc.co.uk/news/health-20983324</gtr:url><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Cambridge Science Festival 2014</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>A6976DDF-D30F-404E-8256-B1970A77E419</gtr:id><gtr:impact>Researchers discussed their work and coordinated activities for the public such as DNA extraction.

Increased awareness of cancer research and its importance</gtr:impact><gtr:outcomeId>543e4fb9dd92e0.88615847</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>BBC R4 Case Notes on Barrett's oesophagus.</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>0A7B7492-2D03-4936-8483-A82F3F203A51</gtr:id><gtr:impact>Case Notes health programme broadcast nationally on BBC Radio4 focussed on my research on Barrett's oesophagus and cancer.

Increased public awareness and knowledge of this condition.</gtr:impact><gtr:outcomeId>5777FF16BBC</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2009</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Daily Mail news story</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>11A7568E-8762-406B-BFCB-E611B2A20483</gtr:id><gtr:impact>Quoted in feature on oesophageal cancer.

Increased awareness of research project and the disease.</gtr:impact><gtr:outcomeId>R6pBfn483xy</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>http://www.dailymail.co.uk/health/article-2343560/Obesity-fuels-rise-throat-cancer-men-Form-deadliest-diagnosed-late.html</gtr:url><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>MRC Network feature 2010</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>F31CF604-12B2-47D6-8B40-5AB29355837A</gtr:id><gtr:impact>http://www.mrc.ac.uk/Utilities/Documentrecord/index.htm?d=MRC007555

Appeared in a feature on research and diagnostic tools.

Increased profile for research.</gtr:impact><gtr:outcomeId>NyMfvgc7qxQ</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Cam Uni press release</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>79F9BAB7-7319-4BCC-A41F-180D46F8CCD3</gtr:id><gtr:impact>Cambridge University press release on research discovery

Increased awareness of research and its impact, as release was picked up several national and international outlets</gtr:impact><gtr:outcomeId>543e503933dba7.58504500</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>http://www.cam.ac.uk/research/news/oesophageal-cancer-gene-identified</gtr:url><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Feature in The Times</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>7CFCE00F-15C2-4520-936E-BCEDF0A4C967</gtr:id><gtr:impact>Featured in a piece in the T2 section of The Times on heartburn and acid reflux and relationship with Barrett's oesophagus and cancer.

Hard to define but hopefully increased public awareness of risks associated with acid reflux and Barrett's.</gtr:impact><gtr:outcomeId>F34803852DF</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2009</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>MRC Press Release on BMJ paper</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>95A38EF2-4F90-4B2D-876D-37AC7FA30587</gtr:id><gtr:impact>Media release widely picked up by national print and online media such as BBC News Online, Daily Mail, Nursing Times and others.

Greater awareness of research and screening for oesophageal cancer.</gtr:impact><gtr:outcomeId>YThaApUeJZN</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Open Lecture for Society of Chemical Industry</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>A1D62777-34A0-4026-97A9-50D03CDCF1D8</gtr:id><gtr:impact>Lecture on &amp;quot;Improving outcomes for cancer patients&amp;quot;

Improving knowledge and understanding of research amongst a public and professional audience.</gtr:impact><gtr:outcomeId>09A850FBA2F</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2009</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Expert on Guardian Careers online panel</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>0C1DC8E7-825E-4444-B4A6-DC8F11FFD65D</gtr:id><gtr:impact>Took part in online careers session answering questions on biomedical research.

Provided information for those interested in careers in this field.</gtr:impact><gtr:outcomeId>jmmagH5XZgL</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Cambridge Science Festival</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>2470FD4E-F60C-44ED-97EB-5FCBD15203EE</gtr:id><gtr:impact>Part of 'Mysterious magic to modern marvels' display at Festival with range of activities for children.

improved awareness of science and research.</gtr:impact><gtr:outcomeId>0AC266E1C28</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2009</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Appearance on BBC Radio Cambridgeshire</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>B46BA255-0176-4F15-A384-5284A2549A78</gtr:id><gtr:impact>Spoke on BBC Radio Cambridgeshire about heartburn awareness and cancer risk.

Increased awareness of oesophageal cancer and research in the unit.</gtr:impact><gtr:outcomeId>F5VMbzvw56J</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Cambridge Science Festival</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>64B900A7-33AE-4779-B13B-AB30C8625257</gtr:id><gtr:impact>Exhibits and activities for children to promote research and science.

Increase awareness of research.</gtr:impact><gtr:outcomeId>4B81632FF02</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2007,2008,2009</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>News story on BBC Online News (Health)</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>21D5CDC4-2B3F-4683-B9FE-CC92FBBD61C4</gtr:id><gtr:impact>http://www.bbc.co.uk/news/health-13632606

News story

Increased profile</gtr:impact><gtr:outcomeId>SwsSL37fand</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>http://www.bbc.co.uk/news/health-13632606</gtr:url><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>News coverage of research on use of imaging for cancer diagnosis and treatment</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>12F1BBCD-24E5-47BC-B2E8-EBC2A65E763D</gtr:id><gtr:impact>Press coverage of a publication in Nature Medicine:
http://www.mrc.ac.uk/Newspublications/News/MRC008428
http://www.dailymail.co.uk/health/article-2087172/Fluorescent-spray-catch-throat-cancer-early-offers-hope-8-000-Britons-diagnosed-year.html?ito=feeds-newsxml

Increased awareness of oesophageal cancer and research in the unit.</gtr:impact><gtr:outcomeId>X9w7XakZs4D</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:url>http://www.mrc.ac.uk/Newspublications/News/MRC008428</gtr:url><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>MRC Network</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>C9ACD2E4-2AD4-444B-A22E-3BCF54DBB261</gtr:id><gtr:impact>MRC Network (Sept/Oct) wrote an article on our public outreach work in schools and our new outreach tool Norman. http://www.mrc.ac.uk/Utilities/Documentrecord/index.htm?d=MRC006370

Increased awareness of our outreach work amongst public and MRC community</gtr:impact><gtr:outcomeId>B9DA69879F7</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>http://www.mrc.ac.uk/Utilities/Documentrecord/index.htm?d=MRC006370</gtr:url><gtr:year>2009</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>MRC Centenary Open Day</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>B9717E95-6996-4A2B-A1C5-430A0FAB32D6</gtr:id><gtr:impact>Around 100 pupils and teachers took part in hands-on activiities in the lab and heard from cancer researchers about their careers.

Increased profile for Unit and increase in engagment with local schools.</gtr:impact><gtr:outcomeId>jXLmwCM1Mcz</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Appearance on BBC Look East</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>9DB90190-10C8-4952-80ED-77B44697A1C5</gtr:id><gtr:impact>Research featured on regional news following award of NHS innovation prize.

Raised profile of research and hopefully increased awareness amongst potential research participants.</gtr:impact><gtr:outcomeId>Uv7sVKmtnr2</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Visit to Parliament as part of MRC Showcase event</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>A127AF0B-4365-41F7-AEBF-09EE77D31764</gtr:id><gtr:impact>Informed MPs about impact of research.

Increased research and MRC profile.</gtr:impact><gtr:outcomeId>pjWeGK4JyDL</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Policymakers/parliamentarians</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Addenbrookes Healthcare Careers Day</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>8D0C7C3E-B947-46F1-B390-10560076CD41</gtr:id><gtr:impact>Around 15 pupils attended the session on medicine and research careers.

Feedback described the session as the best of the day.</gtr:impact><gtr:outcomeId>QWA1rLkmJsn</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Channel 4 television</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>B0F29700-C39D-4301-BD5D-28958A53DBAD</gtr:id><gtr:impact>Cytosponge device appeared on C4's Embarrassing Bodies bodies, along with information on risks of heartburn and cancer

Increased awareness of risk associated with heartburn and of new diagnostic device</gtr:impact><gtr:outcomeId>543e50b81884f3.94623360</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Cambridge Science Festival 2013</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>DC93980A-967C-4F22-8D8E-0D5EAE5F485D</gtr:id><gtr:impact>Around 4000 visitors passed through the biology zone and were able to take part in hands on activities to learn about cancer research.

Increased unit profile and awareness of research.</gtr:impact><gtr:outcomeId>TYtz8EHYgR6</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>MRC Press Release</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>835F2F29-7FC6-4FC1-94C4-FB11079B1B4D</gtr:id><gtr:impact>Vitamin A inhibitors could help prevent gullet cancer http://www.mrc.ac.uk/Newspublications/News/MRC003468

Increasing awareness of research.</gtr:impact><gtr:outcomeId>8C0A06AE577</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>http://www.mrc.ac.uk/Newspublications/News/MRC003468</gtr:url><gtr:year>2007</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>BBC News story 2013</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>0598ED0A-7ECD-4A5A-BE39-C1A8521E3F96</gtr:id><gtr:impact>Quoted and research project described in feature- http://www.bbc.co.uk/news/health-22940088

Increased profile for research and awareness of oesophageal cancer and risks.</gtr:impact><gtr:outcomeId>H5iBJA8vL7H</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>http://www.bbc.co.uk/news/health-22940088</gtr:url><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Cambridge Science Festival</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>DE2F9271-BAAA-4E55-B514-32BEDEAEEE0A</gtr:id><gtr:impact>Around 2000 visitors passed through the Biology Zone where the CCU stand was located. We spoke to many adults about cancer research as children took part in hands on activities.

Increased awareness of cancer research and the work of the unit.</gtr:impact><gtr:outcomeId>DaW7vLPPYGS</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Feature in Cambridge News</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>0E9D77D4-01F0-4B29-9485-394E6DA75B38</gtr:id><gtr:impact>Appeared in a feature on the Unit in the Cambridge News, the city's local newspaper which has regional reach across the county. Feature included in both print and online versions, increasing audience. http://www.cambridge-news.co.uk/Health/Health-and-wellbeing/A-decade-of-discovery-in-cancer-fight-at-Addenbrookes-30042012.htm

Increased awareness of cancer research and the work of the unit.</gtr:impact><gtr:outcomeId>Ya5QZntffWb</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>http://www.cambridge-news.co.uk/Health/Health-and-wellbeing/A-decade-of-discovery-in-cancer-fight-at-Addenbrookes-30042012.htm</gtr:url><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>News story in Daily Mail</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>EE8EEAAB-4C2C-4DD0-A2AF-DBFADC7289E6</gtr:id><gtr:impact>Interviewed for DM news piece on oesophageal cancer
http://www.dailymail.co.uk/health/article-1394952/You-die-heartburn-Mike-told-wife--tragically-wrong.html

Increased research profile</gtr:impact><gtr:outcomeId>fnmVvCxE2vy</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>http://www.dailymail.co.uk/health/article-1394952/You-die-heartburn-Mike-told-wife--tragically-wrong.html</gtr:url><gtr:year>2011</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>40000</gtr:amountPounds><gtr:country>United States of America</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Tri-Path Project Grant - BEST Study</gtr:description><gtr:end>2011-03-02</gtr:end><gtr:fundingOrg>Becton, Dickinson and Company (BD)</gtr:fundingOrg><gtr:id>B1C4167E-C5B5-4B80-8F81-4657D63A6679</gtr:id><gtr:outcomeId>1FA254BBABA0</gtr:outcomeId><gtr:sector>Private</gtr:sector><gtr:start>2009-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1800000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>NIHR Professorship</gtr:description><gtr:end>2017-12-02</gtr:end><gtr:fundingOrg>National Institute for Health Research</gtr:fundingOrg><gtr:fundingRef>NIHR/RP-R2-12-011</gtr:fundingRef><gtr:id>D78441D1-A838-482D-9E5C-11319AFBB354</gtr:id><gtr:outcomeId>rXaxpSJJ6fu</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>30000</gtr:amountPounds><gtr:country>United States of America</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>McCord Foundation Prize</gtr:description><gtr:end>2011-02-02</gtr:end><gtr:fundingOrg>McCord Research Foundation</gtr:fundingOrg><gtr:id>488DB5B9-949B-424D-B0F3-96298BE75366</gtr:id><gtr:outcomeId>793A54D7C690</gtr:outcomeId><gtr:sector>Private</gtr:sector><gtr:start>2009-03-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>15000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>Clinical Research Facilities</gtr:department><gtr:description>Queen Mary University Project Grant</gtr:description><gtr:end>2014-02-02</gtr:end><gtr:fundingOrg>Queen Mary University of London</gtr:fundingOrg><gtr:fundingRef>13/WA/0151</gtr:fundingRef><gtr:id>7865648D-29B2-4817-8E69-64FB11BDB007</gtr:id><gtr:outcomeId>545f37824572f0.61804530</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1200000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>CRUK Project Grant</gtr:description><gtr:end>2014-08-02</gtr:end><gtr:fundingOrg>Cancer Research UK</gtr:fundingOrg><gtr:fundingRef>C14478/A12088</gtr:fundingRef><gtr:id>B0C1612A-AE4B-4573-9701-8AF855BF889E</gtr:id><gtr:outcomeId>pPD5wdWuWto</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2011-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>31491</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>West Anglia CLRN Support Costs</gtr:description><gtr:end>2014-11-02</gtr:end><gtr:fundingOrg>National Institute for Health Research</gtr:fundingOrg><gtr:id>3A6CA0E8-8AA7-4C4C-9C35-D61B91F464DF</gtr:id><gtr:outcomeId>aCmE2CKDui8</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2013-12-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>40000</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>Seventh Framework Programme (FP7)</gtr:department><gtr:description>BETRNET</gtr:description><gtr:end>2013-08-02</gtr:end><gtr:fundingOrg>European Commission</gtr:fundingOrg><gtr:id>F80E53B0-70E2-4E92-BDC9-42A9B22A93DC</gtr:id><gtr:outcomeId>XyzBpG79Pea</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2012-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>136000</gtr:amountPounds><gtr:country>Global</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>GSK Project grant</gtr:description><gtr:end>2010-10-02</gtr:end><gtr:fundingOrg>GlaxoSmithKline (GSK)</gtr:fundingOrg><gtr:id>A46BF3A5-C3A9-47A9-A22A-8A859F1DBA43</gtr:id><gtr:outcomeId>C3FCCEE7B0F0</gtr:outcomeId><gtr:sector>Private</gtr:sector><gtr:start>2007-11-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>23186</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Institute of Cancer - Shannon</gtr:description><gtr:end>2010-09-02</gtr:end><gtr:fundingOrg>Institute of Cancer Research UK</gtr:fundingOrg><gtr:id>DAEE62EE-BC45-4159-A885-10DC83EA12FA</gtr:id><gtr:outcomeId>B9721E15FB20</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2007-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>2000000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>CRUK Project Award - OCCAMS</gtr:description><gtr:end>2017-03-02</gtr:end><gtr:fundingOrg>Cancer Research UK</gtr:fundingOrg><gtr:fundingRef>C1478/A15874</gtr:fundingRef><gtr:id>4A6EB101-FFC5-4796-AA45-8C262810AC0C</gtr:id><gtr:outcomeId>MpEo7mtckkc</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2013-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>160131</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>CCC PhD Studentship-RFE</gtr:description><gtr:end>2015-10-02</gtr:end><gtr:fundingOrg>Cambridge Cancer Centre</gtr:fundingOrg><gtr:id>29CB53EF-7995-44DC-879A-41F1C4A8628B</gtr:id><gtr:outcomeId>cNWzELVbtEu</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>200000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Lister Research Prize Fellowship (Translational research programme for prevention of oesophageal adenocarcinoma)</gtr:description><gtr:end>2012-07-02</gtr:end><gtr:fundingOrg>Lister Institute of Preventive Medicine</gtr:fundingOrg><gtr:id>600011A6-C881-4CB2-A6FB-5C7E99EF309E</gtr:id><gtr:outcomeId>7E1DB42F46C0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2009-07-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>94000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>The Evelyn Trust</gtr:description><gtr:end>2013-03-02</gtr:end><gtr:fundingOrg>The Evelyn Trust</gtr:fundingOrg><gtr:id>8DB8A845-BE3A-44C1-B0EB-FF7936D0D385</gtr:id><gtr:outcomeId>P4h5TtEKJrt0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2010-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>147000</gtr:amountPounds><gtr:country>United States of America</gtr:country><gtr:currCode>USD</gtr:currCode><gtr:currCountryCode>Ecuador</gtr:currCountryCode><gtr:currLang>es_EC</gtr:currLang><gtr:description>ASGE</gtr:description><gtr:end>2013-08-02</gtr:end><gtr:fundingOrg>American Society for Gastrointestinal Endoscopy?(ASGE)</gtr:fundingOrg><gtr:id>2F2C51BD-1B40-4EE5-991F-E1E1CC870A1B</gtr:id><gtr:outcomeId>DfprJvSHho5</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2012-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>216762</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>BUPA Foundation</gtr:department><gtr:description>BUPA Foundation Project Grant</gtr:description><gtr:end>2012-03-02</gtr:end><gtr:fundingOrg>BUPA</gtr:fundingOrg><gtr:id>E037528A-4EDE-47BB-9536-36DE75538638</gtr:id><gtr:outcomeId>2A0B53E7D700</gtr:outcomeId><gtr:sector>Private</gtr:sector><gtr:start>2009-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>216658</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Development Gap Funding - BEST study</gtr:description><gtr:end>2010-03-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>86207AF8-0D4C-4FE0-91BA-35AB8E9458F2</gtr:id><gtr:outcomeId>9C63DDE10190</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2007-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>25800</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>BMA Gunton Award 2009</gtr:description><gtr:end>2011-08-02</gtr:end><gtr:fundingOrg>British Medical Association (BMA)</gtr:fundingOrg><gtr:id>DD847969-9DB4-40F4-9027-DF99DB2A04C5</gtr:id><gtr:outcomeId>493A220EBBF0</gtr:outcomeId><gtr:sector>Learned Society</gtr:sector><gtr:start>2009-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>3350</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Ida Darwin Project Grant - BEST study</gtr:description><gtr:end>2010-03-02</gtr:end><gtr:fundingOrg>Addenbrooke's Hospital</gtr:fundingOrg><gtr:id>EFCE8B34-E1C9-4A45-81C8-15625AE65004</gtr:id><gtr:outcomeId>401895003390</gtr:outcomeId><gtr:sector>Hospitals</gtr:sector><gtr:start>2009-04-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs><gtr:intellectualPropertyOutput><gtr:description>Method and kit to aid the diagnosis of Barrett's oesophagus or Barrett's associated dysplasia. The kit comprises a device to collect cells for cytological analysis.</gtr:description><gtr:grantRef>MC_U105365007</gtr:grantRef><gtr:id>29C144BF-CB1E-48BD-98E0-48F51F1BFC89</gtr:id><gtr:impact>Method and kit to aid the diagnosis of Barrett's oesophagus or Barrett's associated dysplasia. The kit comprises a device to collect cells for cytological analysis.</gtr:impact><gtr:licensed>No</gtr:licensed><gtr:outcomeId>6A194028183</gtr:outcomeId><gtr:patentId>US2009286237</gtr:patentId><gtr:protection>Patent granted</gtr:protection><gtr:title>Barrett's Kit</gtr:title><gtr:yearProtectionGranted>2009</gtr:yearProtectionGranted></gtr:intellectualPropertyOutput><gtr:intellectualPropertyOutput><gtr:description>Risk stratification (prediction of likelihood) for progression from Barrett's Esophagus to high grade dysplasia (EAC), using the signature Lectin/DNA content abnormality/CA19-9/CyclinA/p53.</gtr:description><gtr:grantRef>MC_U105365007</gtr:grantRef><gtr:id>8D6AFEBB-82E4-481C-9B8A-5F19A1B93EA6</gtr:id><gtr:impact>None to date.</gtr:impact><gtr:licensed>No</gtr:licensed><gtr:outcomeId>fuLsAkQGoyr</gtr:outcomeId><gtr:patentId>GB1208756.5</gtr:patentId><gtr:protection>Patent application published</gtr:protection><gtr:title>Risk stratification (prediction of likelihood) for progression from BE to high grade dysplasia (EAC)</gtr:title><gtr:yearProtectionGranted>2012</gtr:yearProtectionGranted></gtr:intellectualPropertyOutput><gtr:intellectualPropertyOutput><gtr:description>Improved sponge/capsule device for cell collection</gtr:description><gtr:grantRef>MC_U105365007</gtr:grantRef><gtr:id>833778A9-1BB2-4341-8900-063E47B744C7</gtr:id><gtr:impact>Unknown
PATENT APPLICATION TERMINATED 2010</gtr:impact><gtr:licensed>No</gtr:licensed><gtr:outcomeId>Z8W8zfwZomW</gtr:outcomeId><gtr:patentId>GB0920014.8</gtr:patentId><gtr:protection>Patent application published</gtr:protection><gtr:title>Improved oesophagus sponge</gtr:title><gtr:yearProtectionGranted>2009</gtr:yearProtectionGranted></gtr:intellectualPropertyOutput><gtr:intellectualPropertyOutput><gtr:description>Diagnosis of inconspicuous or early stage dysplasia, using the 4 gene signature SLC22A18/PIGR/GJA12/RIN2</gtr:description><gtr:grantRef>MC_U105365007</gtr:grantRef><gtr:id>2BFFCA7D-F001-47CD-995F-D81DD8B3B9B4</gtr:id><gtr:impact>None to date.</gtr:impact><gtr:licensed>No</gtr:licensed><gtr:outcomeId>Y3aXYSUgLVP</gtr:outcomeId><gtr:patentId>GB1208874.6</gtr:patentId><gtr:protection>Patent application published</gtr:protection><gtr:title>diagnosis of inconspicuous or early stage dysplasia</gtr:title><gtr:yearProtectionGranted>2012</gtr:yearProtectionGranted></gtr:intellectualPropertyOutput><gtr:intellectualPropertyOutput><gtr:description>TIME diagnosis of high grade dysplasia (EAC), using Imaging endoscopy (AFI) plus aneuploidy/p53/cyclinA</gtr:description><gtr:grantRef>MC_U105365007</gtr:grantRef><gtr:id>93F3FB08-2C0E-4FA4-907A-CED39C4A2AF7</gtr:id><gtr:impact>None to date</gtr:impact><gtr:licensed>No</gtr:licensed><gtr:outcomeId>cZqaAzyLqex</gtr:outcomeId><gtr:patentId>GB1208963.7</gtr:patentId><gtr:protection>Patent application published</gtr:protection><gtr:title>TIME diagnosis of high grade dysplasia</gtr:title><gtr:yearProtectionGranted>2012</gtr:yearProtectionGranted></gtr:intellectualPropertyOutput><gtr:intellectualPropertyOutput><gtr:description>Four gene signature for use in diagnosis of oesophageal cancer.</gtr:description><gtr:grantRef>MC_U105365007</gtr:grantRef><gtr:id>BFC67FCC-38A8-431E-9AA7-9C8F483BA0ED</gtr:id><gtr:impact>development for use in screening
PATENT APPLICATION TERMINATED 2011</gtr:impact><gtr:licensed>No</gtr:licensed><gtr:outcomeId>PorXGHXfYDu</gtr:outcomeId><gtr:patentId>GB1005048.2</gtr:patentId><gtr:protection>Patent application published</gtr:protection><gtr:title>Oesophageal prognostic signature</gtr:title><gtr:yearProtectionGranted>2010</gtr:yearProtectionGranted></gtr:intellectualPropertyOutput><gtr:intellectualPropertyOutput><gtr:description>Methods of detection of benign conditions of the oesophagus, using the cytosponge.</gtr:description><gtr:grantRef>MC_U105365007</gtr:grantRef><gtr:id>9442B1DD-FFC7-48F1-9EEE-280728AAE524</gtr:id><gtr:impact>None.</gtr:impact><gtr:licensed>No</gtr:licensed><gtr:outcomeId>V9U2aXCWtY7</gtr:outcomeId><gtr:patentId>GB1120162.1</gtr:patentId><gtr:protection>Patent application published</gtr:protection><gtr:title>Methods of detection of benign conditions</gtr:title><gtr:yearProtectionGranted>2011</gtr:yearProtectionGranted></gtr:intellectualPropertyOutput></gtr:intellectualPropertyOutputs><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs><gtr:productOutput><gtr:clinicalTrial>true</gtr:clinicalTrial><gtr:description>The Cytosponge is a cell colection device which when coupled with a molecular marker can be used to diagnose Barrett's oesophagus in the primary care setting</gtr:description><gtr:id>087EB01F-25AB-447B-9956-FC45DF46F2C1</gtr:id><gtr:impact>This has now been awarded funding by CRUK for further evaluation in a large-scale clincial trial</gtr:impact><gtr:outcomeId>286964E7402</gtr:outcomeId><gtr:stage>Early clinical assessment</gtr:stage><gtr:status>Under active development/distribution</gtr:status><gtr:title>Cytosponge</gtr:title><gtr:type>Diagnostic Tool - Non-Imaging</gtr:type><gtr:yearDevCompleted>2008</gtr:yearDevCompleted></gtr:productOutput></gtr:productOutputs><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>A new screening tool was developed and patented which involves a cell collection device suitable for primary care in combination with a molecular marker</gtr:description><gtr:id>CA21C460-A2F5-4665-94B8-1ECE61E2568A</gtr:id><gtr:impact>PMID: 19651633 [PubMed - in process]</gtr:impact><gtr:outcomeId>BDDA4308EB0</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Cytosponge screening device</gtr:title><gtr:type>Technology assay or reagent</gtr:type><gtr:url>http://europepmc.org/abstract/MED/19651633</gtr:url></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>The grant funding covered infrastructure and staff support for the Northern Ireland Population Register of Barrett's oesophagus</gtr:description><gtr:id>B9F7DE3F-EF84-45D9-B4D3-910568607AB6</gtr:id><gtr:impact>still in progress</gtr:impact><gtr:outcomeId>92D4A6B89A4</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>up to date population based cohort database Barrett's samples</gtr:title><gtr:type>Biological samples</gtr:type></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>OCCAMS is a retrospective mutlicnetre UK database of oesophago-gastric cnacers with clinical outcome data. This is now being expanded to a prospective database which will also include tissue samples</gtr:description><gtr:id>D9D8907A-C5D9-4A73-824D-039BEC095BC3</gtr:id><gtr:impact>paper under review</gtr:impact><gtr:outcomeId>CF78D02F0E8</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>OCCAMS</gtr:title><gtr:type>Biological samples</gtr:type></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>D5744F7F-00D7-4EFD-94AC-804321BD3F49</gtr:id><gtr:title>The combination of autofluorescence endoscopy and molecular biomarkers is a novel diagnostic tool for dysplasia in Barrett's oesophagus.</gtr:title><gtr:parentPublicationTitle>Gut</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/373e5f2601312795ff85b771b27a9a1a"><gtr:id>373e5f2601312795ff85b771b27a9a1a</gtr:id><gtr:otherNames>di Pietro M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0017-5749</gtr:issn><gtr:outcomeId>5436a478000fd0.72021721</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4F2BCF73-090A-430B-9A3D-2122CA748E28</gtr:id><gtr:title>Mechanisms and sequelae of E-cadherin silencing in hereditary diffuse gastric cancer.</gtr:title><gtr:parentPublicationTitle>The Journal of pathology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6a7678d5f58c189c745f4c120fbbaf7b"><gtr:id>6a7678d5f58c189c745f4c120fbbaf7b</gtr:id><gtr:otherNames>Barber M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0022-3417</gtr:issn><gtr:outcomeId>A604F28F1D6</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C62947E6-F4E4-40F7-A0BA-6B782376AB39</gtr:id><gtr:title>Biomarkers in Barrett's esophagus and esophageal adenocarcinoma: predictors of progression and prognosis.</gtr:title><gtr:parentPublicationTitle>World journal of gastroenterology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f77a23e90924b6cb387a5bcd289ef40d"><gtr:id>f77a23e90924b6cb387a5bcd289ef40d</gtr:id><gtr:otherNames>Ong CA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1007-9327</gtr:issn><gtr:outcomeId>Yk5ScsXwZjH</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9B2D8A50-E223-471D-9000-70DA842DD919</gtr:id><gtr:title>Analysis of dysplasia in patients with Barrett's esophagus based on expression pattern of 90 genes.</gtr:title><gtr:parentPublicationTitle>Gastroenterology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/88d1d6f25e0a2795c15b7fb9b7cba37e"><gtr:id>88d1d6f25e0a2795c15b7fb9b7cba37e</gtr:id><gtr:otherNames>Varghese S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0016-5085</gtr:issn><gtr:outcomeId>561cce9e120046.09744356</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4B9253DE-D29A-444C-B794-03EF9F125E91</gtr:id><gtr:title>Identification and clinical implementation of biomarkers for Barrett's esophagus.</gtr:title><gtr:parentPublicationTitle>Gastroenterology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/88d1d6f25e0a2795c15b7fb9b7cba37e"><gtr:id>88d1d6f25e0a2795c15b7fb9b7cba37e</gtr:id><gtr:otherNames>Varghese S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0016-5085</gtr:issn><gtr:outcomeId>pm_13321_21_22266150</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>72EF8A50-E8BE-4A24-A691-82A2D2E351DB</gtr:id><gtr:title>Hereditary diffuse gastric cancer: updated consensus guidelines for clinical management and directions for future research.</gtr:title><gtr:parentPublicationTitle>Journal of medical genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f294d8b5abbe524be5d408e57d9b56ec"><gtr:id>f294d8b5abbe524be5d408e57d9b56ec</gtr:id><gtr:otherNames>Fitzgerald RC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0022-2593</gtr:issn><gtr:outcomeId>Px1ueQG6bWy</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>98999940-B705-4832-BD41-8DA007F9DE2B</gtr:id><gtr:title>Health benefits and cost effectiveness of endoscopic and nonendoscopic cytosponge screening for Barrett's esophagus.</gtr:title><gtr:parentPublicationTitle>Gastroenterology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/845665cb9899c2c569a59c3b93056cf7"><gtr:id>845665cb9899c2c569a59c3b93056cf7</gtr:id><gtr:otherNames>Benaglia T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0016-5085</gtr:issn><gtr:outcomeId>pm_13321_21_23041329</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E795D4D4-81B4-498B-8072-881B02A669B5</gtr:id><gtr:title>Non-endoscopic screening biomarkers for Barrett's oesophagus: from microarray analysis to the clinic.</gtr:title><gtr:parentPublicationTitle>Gut</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e1f129ca0f3f3de3bd6850d65b2b2bde"><gtr:id>e1f129ca0f3f3de3bd6850d65b2b2bde</gtr:id><gtr:otherNames>Lao-Sirieix P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0017-5749</gtr:issn><gtr:outcomeId>A87360AF626</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0B14CD9B-E0A0-4DC2-B730-15F787EB0016</gtr:id><gtr:title>Effect of acid suppression on molecular predictors for esophageal cancer.</gtr:title><gtr:parentPublicationTitle>Cancer epidemiology, biomarkers &amp; prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e1f129ca0f3f3de3bd6850d65b2b2bde"><gtr:id>e1f129ca0f3f3de3bd6850d65b2b2bde</gtr:id><gtr:otherNames>Lao-Sirieix P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>1055-9965</gtr:issn><gtr:outcomeId>900DE15E123</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>98083418-75E8-4D69-9454-BB2A97E8DC9A</gtr:id><gtr:title>Short segment columnar-lined oesophagus: an underestimated cancer risk? A large cohort study of the relationship between Barrett's columnar-lined oesophagus segment length and adenocarcinoma risk.</gtr:title><gtr:parentPublicationTitle>European journal of gastroenterology &amp; hepatology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a0f74c90c5e380030f0b8fc2660bbbbf"><gtr:id>a0f74c90c5e380030f0b8fc2660bbbbf</gtr:id><gtr:otherNames>Gatenby PA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0954-691X</gtr:issn><gtr:outcomeId>03E07F973E0</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4CB44E3A-B68E-4D0C-BCCE-092F76A9EFB5</gtr:id><gtr:title>Integrative post-genome-wide association analysis of CDKN2A and TP53 SNPs and risk of esophageal adenocarcinoma.</gtr:title><gtr:parentPublicationTitle>Carcinogenesis</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/51369dd875ec772c77b28c7d2865e351"><gtr:id>51369dd875ec772c77b28c7d2865e351</gtr:id><gtr:otherNames>Buas MF</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0143-3334</gtr:issn><gtr:outcomeId>5436a475a15943.56849373</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B4CADE2F-58FE-423A-AC0E-F02307533DF3</gtr:id><gtr:title>Molecular basis of Barrett's oesophagus and oesophageal adenocarcinoma.</gtr:title><gtr:parentPublicationTitle>Gut</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f294d8b5abbe524be5d408e57d9b56ec"><gtr:id>f294d8b5abbe524be5d408e57d9b56ec</gtr:id><gtr:otherNames>Fitzgerald RC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0017-5749</gtr:issn><gtr:outcomeId>49C177B856F</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A7628D3D-927F-41AB-A83A-05D5ABA677C2</gtr:id><gtr:title>Early diagnosis of oesophageal cancer.</gtr:title><gtr:parentPublicationTitle>British journal of cancer</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/70dccfce42d44c3ddfe1ba747790e1ba"><gtr:id>70dccfce42d44c3ddfe1ba747790e1ba</gtr:id><gtr:otherNames>Bird-Lieberman EL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0007-0920</gtr:issn><gtr:outcomeId>32390EB2110</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F6C6EC67-62E7-4BC8-B6A3-5A0DBC8957FE</gtr:id><gtr:title>Stromal genes discriminate preinvasive from invasive disease, predict outcome, and highlight inflammatory pathways in digestive cancers.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f6cd8cbbac729ab25bf9d16871a86bc8"><gtr:id>f6cd8cbbac729ab25bf9d16871a86bc8</gtr:id><gtr:otherNames>Saadi A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>otBHpxUVPJq</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>73BB5FC9-BC46-451C-980B-5B20E5E12E19</gtr:id><gtr:title>Dissecting out the genetic origins of Barrett's oesophagus.</gtr:title><gtr:parentPublicationTitle>Gut</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f294d8b5abbe524be5d408e57d9b56ec"><gtr:id>f294d8b5abbe524be5d408e57d9b56ec</gtr:id><gtr:otherNames>Fitzgerald RC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0017-5749</gtr:issn><gtr:outcomeId>B5CCE02C041</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>29248B19-91C3-4D24-8347-4D15922EE25E</gtr:id><gtr:title>Physiological and molecular analysis of acid loading mechanisms in squamous and columnar-lined esophagus.</gtr:title><gtr:parentPublicationTitle>Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e1f129ca0f3f3de3bd6850d65b2b2bde"><gtr:id>e1f129ca0f3f3de3bd6850d65b2b2bde</gtr:id><gtr:otherNames>Lao-Sirieix P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1120-8694</gtr:issn><gtr:outcomeId>3DDD94DA3F2</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>442DC54E-EBA8-4CA8-9CD4-45C04ACF694F</gtr:id><gtr:title>Treatment for Barrett's oesophagus.</gtr:title><gtr:parentPublicationTitle>The Cochrane database of systematic reviews</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8811fbbc081c5545637c0d8a965f5575"><gtr:id>8811fbbc081c5545637c0d8a965f5575</gtr:id><gtr:otherNames>Rees JR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1361-6137</gtr:issn><gtr:outcomeId>qHZHXDpQE3a</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0AA5892A-831B-439F-B203-F156CA0928DF</gtr:id><gtr:title>Screening and risk stratification for Barrett's esophagus: how to limit the clinical impact of the increasing incidence of esophageal adenocarcinoma.</gtr:title><gtr:parentPublicationTitle>Gastroenterology clinics of North America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/373e5f2601312795ff85b771b27a9a1a"><gtr:id>373e5f2601312795ff85b771b27a9a1a</gtr:id><gtr:otherNames>di Pietro M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0889-8553</gtr:issn><gtr:outcomeId>pm_13321_21_23452636</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D43AAE30-E570-4080-A74B-CE33C87C51C7</gtr:id><gtr:title>In vivo and in vitro evidence for transforming growth factor-beta1-mediated epithelial to mesenchymal transition in esophageal adenocarcinoma.</gtr:title><gtr:parentPublicationTitle>Cancer research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8811fbbc081c5545637c0d8a965f5575"><gtr:id>8811fbbc081c5545637c0d8a965f5575</gtr:id><gtr:otherNames>Rees JR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0008-5472</gtr:issn><gtr:outcomeId>F3F11213B1A</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8D8C7942-32AA-40A2-994F-60211DF025A5</gtr:id><gtr:title>Cyclin A immunocytology as a risk stratification tool for Barrett's esophagus surveillance.</gtr:title><gtr:parentPublicationTitle>Clinical cancer research : an official journal of the American Association for Cancer Research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e1f129ca0f3f3de3bd6850d65b2b2bde"><gtr:id>e1f129ca0f3f3de3bd6850d65b2b2bde</gtr:id><gtr:otherNames>Lao-Sirieix P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1078-0432</gtr:issn><gtr:outcomeId>33AB662F44F</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>103B5B33-7AAE-4710-BC9F-DDDB9697F5FC</gtr:id><gtr:title>The human squamous oesophagus has widespread capacity for clonal expansion from cells at diverse stages of differentiation.</gtr:title><gtr:parentPublicationTitle>Gut</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9b4df2be14a0c62d43a892f34bb17150"><gtr:id>9b4df2be14a0c62d43a892f34bb17150</gtr:id><gtr:otherNames>Barbera M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0017-5749</gtr:issn><gtr:outcomeId>5436a4782e6e14.02518472</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5CB63115-5789-4BA0-B588-A67F3C68D107</gtr:id><gtr:title>Oracular guidance on clinical management of early neoplastic Barrett's esophagus.</gtr:title><gtr:parentPublicationTitle>Gastroenterology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f294d8b5abbe524be5d408e57d9b56ec"><gtr:id>f294d8b5abbe524be5d408e57d9b56ec</gtr:id><gtr:otherNames>Fitzgerald RC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0016-5085</gtr:issn><gtr:outcomeId>pm_13321_21_22722048</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C33E8D41-8AA4-41C8-B9B1-03AF722F2C13</gtr:id><gtr:title>Selective loss of TGFbeta Smad-dependent signalling prevents cell cycle arrest and promotes invasion in oesophageal adenocarcinoma cell lines.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/35d77a3d75be80d62942d0643d31ff40"><gtr:id>35d77a3d75be80d62942d0643d31ff40</gtr:id><gtr:otherNames>Onwuegbusi BA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>AF4B80B81DF</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>60751F12-002F-4F48-AD1E-F91A3A59B6EF</gtr:id><gtr:title>Research advances in esophageal diseases: bench to bedside.</gtr:title><gtr:parentPublicationTitle>F1000prime reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/373e5f2601312795ff85b771b27a9a1a"><gtr:id>373e5f2601312795ff85b771b27a9a1a</gtr:id><gtr:otherNames>di Pietro M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>2051-7599</gtr:issn><gtr:outcomeId>5436a4788ee611.96847714</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7BDA59B2-38C6-484A-B508-2443003F4459</gtr:id><gtr:title>Barrett's esophagus.</gtr:title><gtr:parentPublicationTitle>Gastroenterology clinics of North America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/70dccfce42d44c3ddfe1ba747790e1ba"><gtr:id>70dccfce42d44c3ddfe1ba747790e1ba</gtr:id><gtr:otherNames>Bird-Lieberman EL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0889-8553</gtr:issn><gtr:outcomeId>5DB391FEAA7</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3EE1B490-DED3-48BE-B868-4CA050BBDFE5</gtr:id><gtr:title>Do transcription factors hold the key to understanding the development of Barrett's esophagus?</gtr:title><gtr:parentPublicationTitle>Digestive diseases and sciences</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f294d8b5abbe524be5d408e57d9b56ec"><gtr:id>f294d8b5abbe524be5d408e57d9b56ec</gtr:id><gtr:otherNames>Fitzgerald RC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0163-2116</gtr:issn><gtr:outcomeId>pm_13321_21_22367064</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9D3B61AD-9ACF-4F03-B662-6FE0473BBC4E</gtr:id><gtr:title>Fluorescence imaging for the detection of early neoplasia in Barrett's esophagus: old looks or new vision?</gtr:title><gtr:parentPublicationTitle>European journal of gastroenterology &amp; hepatology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ef204e0e878695b8ed044ba71c336143"><gtr:id>ef204e0e878695b8ed044ba71c336143</gtr:id><gtr:otherNames>Boerwinkel DF</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0954-691X</gtr:issn><gtr:outcomeId>5436a476ce34b1.20828994</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4DE7A2F3-9669-478B-B205-DA927D17EE88</gtr:id><gtr:title>Endoscopic TriModal imaging and biomarkers for neoplasia conjoined: a feasibility study in Barrett's esophagus.</gtr:title><gtr:parentPublicationTitle>Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ef204e0e878695b8ed044ba71c336143"><gtr:id>ef204e0e878695b8ed044ba71c336143</gtr:id><gtr:otherNames>Boerwinkel DF</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1120-8694</gtr:issn><gtr:outcomeId>pm_13321_21_23067399</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C754D7DE-7C93-4F56-9B83-D802DA0C21F1</gtr:id><gtr:title>DNA methylation as an adjunct to histopathology to detect prevalent, inconspicuous dysplasia and early-stage neoplasia in Barrett's esophagus.</gtr:title><gtr:parentPublicationTitle>Clinical cancer research : an official journal of the American Association for Cancer Research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1f17ac07c973c84943fa207facf1e836"><gtr:id>1f17ac07c973c84943fa207facf1e836</gtr:id><gtr:otherNames>Alvi MA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1078-0432</gtr:issn><gtr:outcomeId>pm_13321_21_23243219</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8919B901-F49E-4D39-B9E4-9F1F7CBD80ED</gtr:id><gtr:title>Ordering of mutations in preinvasive disease stages of esophageal carcinogenesis.</gtr:title><gtr:parentPublicationTitle>Nature genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/374f58aed2c059b62f2efd7a5fea2b87"><gtr:id>374f58aed2c059b62f2efd7a5fea2b87</gtr:id><gtr:otherNames>Weaver JMJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1061-4036</gtr:issn><gtr:outcomeId>5436a476945004.40300873</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8F65FE97-5A67-42E2-AFCA-0CFB59CAE267</gtr:id><gtr:title>Accuracy, safety, and tolerability of tissue collection by Cytosponge vs endoscopy for evaluation of eosinophilic esophagitis.</gtr:title><gtr:parentPublicationTitle>Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1d4e381eca74360f552e32796317a15e"><gtr:id>1d4e381eca74360f552e32796317a15e</gtr:id><gtr:otherNames>Katzka DA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1542-3565</gtr:issn><gtr:outcomeId>5436a4764d76c0.86249731</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4E9CDE40-81CE-42FC-9238-A51A11A03B4E</gtr:id><gtr:title>The influence of symptom type and duration on the fate of the metaplastic columnar-lined Barrett's oesophagus.</gtr:title><gtr:parentPublicationTitle>Alimentary pharmacology &amp; therapeutics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a0f74c90c5e380030f0b8fc2660bbbbf"><gtr:id>a0f74c90c5e380030f0b8fc2660bbbbf</gtr:id><gtr:otherNames>Gatenby PA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0269-2813</gtr:issn><gtr:outcomeId>D55FEBD5EB5</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9A0032CC-568C-4A72-BBC6-89A4A55515D1</gtr:id><gtr:title>Polymorphisms in Genes of Relevance for Oestrogen and Oxytocin Pathways and Risk of Barrett's Oesophagus and Oesophageal Adenocarcinoma: A Pooled Analysis from the BEACON Consortium.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/97770544f1aa7371a15d1d4df5cb8d0b"><gtr:id>97770544f1aa7371a15d1d4df5cb8d0b</gtr:id><gtr:otherNames>Lagergren K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>561cce9dddbf14.98090612</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>22290AF9-4C65-4DBD-852C-47C4E52FB124</gtr:id><gtr:title>Comparative genomic hybridization of esophageal adenocarcinoma and squamous cell carcinoma cell lines.</gtr:title><gtr:parentPublicationTitle>Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9d6dd3d9afba97accab856b063add869"><gtr:id>9d6dd3d9afba97accab856b063add869</gtr:id><gtr:otherNames>Su M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>1120-8694</gtr:issn><gtr:outcomeId>CE722740F67</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C6C9CEC0-DBF2-41BC-8452-50EC1FEF2BF2</gtr:id><gtr:title>Let's not jump to conclusions regarding low-grade dysplasia in Barrett's esophagus.</gtr:title><gtr:parentPublicationTitle>Gastroenterology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/016e5852aefdf9532c59b079aef860c3"><gtr:id>016e5852aefdf9532c59b079aef860c3</gtr:id><gtr:otherNames>Bergman JJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0016-5085</gtr:issn><gtr:outcomeId>pm_13321_21_22449581</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5C75F95A-C9D7-4614-90F3-BA6769A74447</gtr:id><gtr:title>Evidence for a functional role of epigenetically regulated midcluster HOXB genes in the development of Barrett esophagus.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/373e5f2601312795ff85b771b27a9a1a"><gtr:id>373e5f2601312795ff85b771b27a9a1a</gtr:id><gtr:otherNames>di Pietro M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>pm_13321_21_22603795</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>66D13181-7CF9-42A8-BBF0-D41BDA66B1DC</gtr:id><gtr:title>Barrett's oesophagus: an ideal model to study cancer genetics.</gtr:title><gtr:parentPublicationTitle>Human genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/373e5f2601312795ff85b771b27a9a1a"><gtr:id>373e5f2601312795ff85b771b27a9a1a</gtr:id><gtr:otherNames>di Pietro M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0340-6717</gtr:issn><gtr:outcomeId>7969469AB29</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5F9B8C62-DD92-4385-95E4-C41494F045F9</gtr:id><gtr:title>Gastro-esophageal reflux disease symptoms and demographic factors as a pre-screening tool for Barrett's esophagus.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/42f7c7c6107a6cd7198876022cb295cf"><gtr:id>42f7c7c6107a6cd7198876022cb295cf</gtr:id><gtr:otherNames>Liu X</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>5436a477a98d20.80896702</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C90ADCE7-D644-4727-AFE2-67E6BFB99703</gtr:id><gtr:title>Retinoic acid-induced glandular differentiation of the oesophagus.</gtr:title><gtr:parentPublicationTitle>Gut</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/066d29ad97b024c2a8ff7b1a2a2e0ede"><gtr:id>066d29ad97b024c2a8ff7b1a2a2e0ede</gtr:id><gtr:otherNames>Chang CL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0017-5749</gtr:issn><gtr:outcomeId>C360E26EF21</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>70EA8164-1EAA-4716-AA65-1970DA927866</gtr:id><gtr:title>Integrative analysis of array-comparative genomic hybridisation and matched gene expression profiling data reveals novel genes with prognostic significance in oesophageal adenocarcinoma.</gtr:title><gtr:parentPublicationTitle>Gut</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/26411c5ba09e6ded41fbd20eb498ae91"><gtr:id>26411c5ba09e6ded41fbd20eb498ae91</gtr:id><gtr:otherNames>Goh XY</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0017-5749</gtr:issn><gtr:outcomeId>Q9LdFxWrZRv</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DE33CD3E-437C-4D9D-9617-CBE8C6CBBD2A</gtr:id><gtr:title>Screening for oesophageal cancer.</gtr:title><gtr:parentPublicationTitle>Nature reviews. Clinical oncology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e1f129ca0f3f3de3bd6850d65b2b2bde"><gtr:id>e1f129ca0f3f3de3bd6850d65b2b2bde</gtr:id><gtr:otherNames>Lao-Sirieix P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1759-4774</gtr:issn><gtr:outcomeId>pm_13321_21_22430857</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>44CF678C-ED5D-4B9D-8769-2ADFF2D3FCB7</gtr:id><gtr:title>Cellular origin of Barrett's metaplasia and oesophageal stem cells.</gtr:title><gtr:parentPublicationTitle>Biochemical Society transactions</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9b4df2be14a0c62d43a892f34bb17150"><gtr:id>9b4df2be14a0c62d43a892f34bb17150</gtr:id><gtr:otherNames>Barbera M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0300-5127</gtr:issn><gtr:outcomeId>FPjy567ArDB</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>67D612D3-EF14-4591-AD1C-81B90B9A9CC3</gtr:id><gtr:title>Prospective cohort study assessing outcomes of patients from families fulfilling criteria for hereditary diffuse gastric cancer undergoing endoscopic surveillance.</gtr:title><gtr:parentPublicationTitle>Gastrointestinal endoscopy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/de14b639cc54247b2d3e4035c7848c9b"><gtr:id>de14b639cc54247b2d3e4035c7848c9b</gtr:id><gtr:otherNames>Lim YC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0016-5107</gtr:issn><gtr:outcomeId>5436a4785ca5b1.39375836</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B48DD5B4-B637-48E9-9FE3-3E1CF5D2B991</gtr:id><gtr:title>Non-endoscopic immunocytological screening test for Barrett's oesophagus.</gtr:title><gtr:parentPublicationTitle>Gut</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e1f129ca0f3f3de3bd6850d65b2b2bde"><gtr:id>e1f129ca0f3f3de3bd6850d65b2b2bde</gtr:id><gtr:otherNames>Lao-Sirieix P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0017-5749</gtr:issn><gtr:outcomeId>826609A3E42</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>90284221-EC0A-42AF-933E-AF0D2A375EF1</gtr:id><gtr:title>A review of the current understanding and clinical utility of miRNAs in esophageal cancer.</gtr:title><gtr:parentPublicationTitle>Seminars in cancer biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ce78660e2f710a4fb2aec735819d3610"><gtr:id>ce78660e2f710a4fb2aec735819d3610</gtr:id><gtr:otherNames>Sakai NS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1044-579X</gtr:issn><gtr:outcomeId>5436a4793c36b5.64789212</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A19B6E69-B0D7-4D1E-8D4C-D2C7256C63A2</gtr:id><gtr:title>Familial gastric cancer - clinical management.</gtr:title><gtr:parentPublicationTitle>Best practice &amp; research. Clinical gastroenterology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f294d8b5abbe524be5d408e57d9b56ec"><gtr:id>f294d8b5abbe524be5d408e57d9b56ec</gtr:id><gtr:otherNames>Fitzgerald RC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>1521-6918</gtr:issn><gtr:outcomeId>3E6EEA96B01</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D54B48B2-338A-4474-BD49-EF81DC59CF01</gtr:id><gtr:title>Characterization of the timing and prevalence of receptor tyrosine kinase expression changes in oesophageal carcinogenesis.</gtr:title><gtr:parentPublicationTitle>The Journal of pathology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e756e2b267556caf4706832aa90154ae"><gtr:id>e756e2b267556caf4706832aa90154ae</gtr:id><gtr:otherNames>Paterson AL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0022-3417</gtr:issn><gtr:outcomeId>pm_13321_21_22733579</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>07E2D53F-4839-4206-9969-6F9904CA788D</gtr:id><gtr:title>Accuracy and Safety of the Cytosponge for Assessing Histologic Activity in Eosinophilic Esophagitis: A Two-Center Study.</gtr:title><gtr:parentPublicationTitle>The American journal of gastroenterology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1d4e381eca74360f552e32796317a15e"><gtr:id>1d4e381eca74360f552e32796317a15e</gtr:id><gtr:otherNames>Katzka DA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0002-9270</gtr:issn><gtr:outcomeId>5a8d8d3ae2e750.87293957</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BCA91024-A54C-4890-94BF-38758BA84ECC</gtr:id><gtr:title>Barrett's Esophagus Translational Research Network (BETRNet): the pivotal role of multi-institutional collaboration in esophageal adenocarcinoma research.</gtr:title><gtr:parentPublicationTitle>Gastroenterology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4635e1c84489b80c09b76bec8d761080"><gtr:id>4635e1c84489b80c09b76bec8d761080</gtr:id><gtr:otherNames>Abrams JA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0016-5085</gtr:issn><gtr:outcomeId>5436a47779c069.72248135</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A05D777C-FAE2-4390-8048-5E9A6BCC9E67</gtr:id><gtr:title>A systematic approach to therapeutic target selection in oesophago-gastric cancer.</gtr:title><gtr:parentPublicationTitle>Gut</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e756e2b267556caf4706832aa90154ae"><gtr:id>e756e2b267556caf4706832aa90154ae</gtr:id><gtr:otherNames>Paterson AL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0017-5749</gtr:issn><gtr:outcomeId>pm_13321_21_22773546</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>898D80ED-3464-49CA-A8AD-32B9602E31FD</gtr:id><gtr:title>Population-based study reveals new risk-stratification biomarker panel for Barrett's esophagus.</gtr:title><gtr:parentPublicationTitle>Gastroenterology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/70dccfce42d44c3ddfe1ba747790e1ba"><gtr:id>70dccfce42d44c3ddfe1ba747790e1ba</gtr:id><gtr:otherNames>Bird-Lieberman EL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0016-5085</gtr:issn><gtr:outcomeId>pm_13321_21_22771507</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>ECE9012A-F05A-4049-9D0E-83C89E28B4C4</gtr:id><gtr:title>Where is the truth when it comes to cancer risk in Barrett's esophagus?</gtr:title><gtr:parentPublicationTitle>Gastroenterology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/373e5f2601312795ff85b771b27a9a1a"><gtr:id>373e5f2601312795ff85b771b27a9a1a</gtr:id><gtr:otherNames>di Pietro M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0016-5085</gtr:issn><gtr:outcomeId>pm_13321_21_22445710</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AD43E8E2-1C73-496D-8785-335CACB01E49</gtr:id><gtr:title>Systematic review: the application of molecular pathogenesis to prevention and treatment of oesophageal adenocarcinoma.</gtr:title><gtr:parentPublicationTitle>Alimentary pharmacology &amp; therapeutics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/78d0a073824302dedfdd350ef449fe29"><gtr:id>78d0a073824302dedfdd350ef449fe29</gtr:id><gtr:otherNames>Peters CJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0269-2813</gtr:issn><gtr:outcomeId>AE7DA2E0558</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2583A04B-EB95-4410-9DDD-AC5F18386AED</gtr:id><gtr:title>Acceptability and accuracy of a non-endoscopic screening test for Barrett's oesophagus in primary care: cohort study.</gtr:title><gtr:parentPublicationTitle>BMJ (Clinical research ed.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/10a87656e0db6dfc89344dae8cba6cb4"><gtr:id>10a87656e0db6dfc89344dae8cba6cb4</gtr:id><gtr:otherNames>Kadri SR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0959-535X</gtr:issn><gtr:outcomeId>GG3GpTZonfJ</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C6079E66-7429-44F0-B62F-34491D89EE41</gtr:id><gtr:title>British Society of Gastroenterology guidelines on the diagnosis and management of Barrett's oesophagus.</gtr:title><gtr:parentPublicationTitle>Gut</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f294d8b5abbe524be5d408e57d9b56ec"><gtr:id>f294d8b5abbe524be5d408e57d9b56ec</gtr:id><gtr:otherNames>Fitzgerald RC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0017-5749</gtr:issn><gtr:outcomeId>5436a478c450a8.66617625</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>26183057-0428-4014-AA4E-4FE59FBF942C</gtr:id><gtr:title>Role of the micro-environment in Barrett's carcinogenesis.</gtr:title><gtr:parentPublicationTitle>Biochemical Society transactions</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e1f129ca0f3f3de3bd6850d65b2b2bde"><gtr:id>e1f129ca0f3f3de3bd6850d65b2b2bde</gtr:id><gtr:otherNames>Lao-Sirieix P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0300-5127</gtr:issn><gtr:outcomeId>QE128gTjs7w</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E3AE576B-98B5-480F-BB4E-1D1609DF98D1</gtr:id><gtr:title>Three-gene immunohistochemical panel adds to clinical staging algorithms to predict prognosis for patients with esophageal adenocarcinoma.</gtr:title><gtr:parentPublicationTitle>Journal of clinical oncology : official journal of the American Society of Clinical Oncology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f77a23e90924b6cb387a5bcd289ef40d"><gtr:id>f77a23e90924b6cb387a5bcd289ef40d</gtr:id><gtr:otherNames>Ong CA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0732-183X</gtr:issn><gtr:outcomeId>pm_13321_21_23509313</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0C4ECDE3-DE08-4135-8EBD-069C328DF303</gtr:id><gtr:title>The '-omics' revolution and oesophageal adenocarcinoma.</gtr:title><gtr:parentPublicationTitle>Nature reviews. Gastroenterology &amp; hepatology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/dbd2f97dc91261683b67b82df4049797"><gtr:id>dbd2f97dc91261683b67b82df4049797</gtr:id><gtr:otherNames>Weaver JM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1759-5045</gtr:issn><gtr:outcomeId>pm_13321_21_23982683</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8C199AFE-6633-4149-80BD-6AC343A95E6D</gtr:id><gtr:title>Generation and validation of a revised classification for oesophageal and junctional adenocarcinoma.</gtr:title><gtr:parentPublicationTitle>The British journal of surgery</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/78d0a073824302dedfdd350ef449fe29"><gtr:id>78d0a073824302dedfdd350ef449fe29</gtr:id><gtr:otherNames>Peters CJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0007-1323</gtr:issn><gtr:outcomeId>B4D3B541C6E</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2C66FA03-35A7-439B-ADC2-8941A14B720E</gtr:id><gtr:title>History, molecular mechanisms, and endoscopic treatment of Barrett's esophagus.</gtr:title><gtr:parentPublicationTitle>Gastroenterology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9870564a2e8de88f196e0e9fbb19380d"><gtr:id>9870564a2e8de88f196e0e9fbb19380d</gtr:id><gtr:otherNames>Spechler SJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0016-5085</gtr:issn><gtr:outcomeId>c8nK1ZN4Ypr</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3AA8670F-53D3-4FDD-9B1F-B33AEDF851FC</gtr:id><gtr:title>Molecular markers for Barrett's esophagus and its progression to cancer.</gtr:title><gtr:parentPublicationTitle>Current opinion in gastroenterology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/526c258f7a9b7def877308c3e49a4b5c"><gtr:id>526c258f7a9b7def877308c3e49a4b5c</gtr:id><gtr:otherNames>Fels Elliott DR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0267-1379</gtr:issn><gtr:outcomeId>pm_13321_21_23689523</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>605BF86C-D033-48E4-8918-572B2E2FBC1C</gtr:id><gtr:title>Pilot study of cytological testing for oesophageal squamous cell dysplasia in a high-risk area in Northern Iran.</gtr:title><gtr:parentPublicationTitle>British journal of cancer</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1e68fc401ce88de3505d9e846e3e64f6"><gtr:id>1e68fc401ce88de3505d9e846e3e64f6</gtr:id><gtr:otherNames>Roshandel G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0007-0920</gtr:issn><gtr:outcomeId>5436a475dff9e7.34306461</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F06DED98-0F74-4180-BE84-34F91EC98208</gtr:id><gtr:title>Polymorphisms in genes in the androgen pathway and risk of Barrett's esophagus and esophageal adenocarcinoma.</gtr:title><gtr:parentPublicationTitle>International journal of cancer</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/91747d3162abaabe8751e4ca4422cd8a"><gtr:id>91747d3162abaabe8751e4ca4422cd8a</gtr:id><gtr:otherNames>Ek WE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0020-7136</gtr:issn><gtr:outcomeId>561cce9db28a17.86367660</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>70BF7AF0-2858-4DFC-8F5F-4FFA79278F72</gtr:id><gtr:title>Molecular imaging using fluorescent lectins permits rapid endoscopic identification of dysplasia in Barrett's esophagus.</gtr:title><gtr:parentPublicationTitle>Nature medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/70dccfce42d44c3ddfe1ba747790e1ba"><gtr:id>70dccfce42d44c3ddfe1ba747790e1ba</gtr:id><gtr:otherNames>Bird-Lieberman EL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1078-8956</gtr:issn><gtr:outcomeId>pm_13321_21_22245781</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F8BA308F-C909-4E8A-9C12-8CA23BD645F8</gtr:id><gtr:title>Amplification of TRIM44: pairing a prognostic target with potential therapeutic strategy.</gtr:title><gtr:parentPublicationTitle>Journal of the National Cancer Institute</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f77a23e90924b6cb387a5bcd289ef40d"><gtr:id>f77a23e90924b6cb387a5bcd289ef40d</gtr:id><gtr:otherNames>Ong CA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0027-8874</gtr:issn><gtr:outcomeId>5436a4773f5604.26067472</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B9E16825-E024-492B-8DEF-A20C779FA7D4</gtr:id><gtr:title>Location of lymph node involvement in patients with esophageal adenocarcinoma predicts survival.</gtr:title><gtr:parentPublicationTitle>World journal of surgery</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fc945f6233c5051ea1507034d6bc942a"><gtr:id>fc945f6233c5051ea1507034d6bc942a</gtr:id><gtr:otherNames>Talsma AK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0364-2313</gtr:issn><gtr:outcomeId>5436a478ef8142.03289032</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2BE704DF-13ED-4F88-91F9-78E6C9C9A06F</gtr:id><gtr:title>Progressive silencing of p14ARF in oesophageal adenocarcinoma.</gtr:title><gtr:parentPublicationTitle>Journal of cellular and molecular medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a2c84b8517fcf40edbdb86bb7a02bba1"><gtr:id>a2c84b8517fcf40edbdb86bb7a02bba1</gtr:id><gtr:otherNames>Huang Y</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1582-1838</gtr:issn><gtr:outcomeId>FE01D1A59FA</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>43A5F303-BCA8-4A86-9284-D222C4BE38E3</gtr:id><gtr:title>Developing a nonendoscopic screening test for Barrett's esophagus.</gtr:title><gtr:parentPublicationTitle>Biomarkers in medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e1a1a028f30f48da3e4cb087a681874b"><gtr:id>e1a1a028f30f48da3e4cb087a681874b</gtr:id><gtr:otherNames>Kadri S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1752-0363</gtr:issn><gtr:outcomeId>aMAki1oit2M</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1E9F7383-4137-47CD-B010-A383AF2A3CA0</gtr:id><gtr:title>Biomarkers for dysplastic Barrett's: ready for prime time?</gtr:title><gtr:parentPublicationTitle>World journal of surgery</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2eba2753aefd9071b33316779022ede0"><gtr:id>2eba2753aefd9071b33316779022ede0</gtr:id><gtr:otherNames>Gregson EM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0364-2313</gtr:issn><gtr:outcomeId>5436a4770f0b27.84279417</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B3C26C24-1699-4040-8D1D-F8FBBF535992</gtr:id><gtr:title>Nitric oxide and acid induce double-strand DNA breaks in Barrett's esophagus carcinogenesis via distinct mechanisms.</gtr:title><gtr:parentPublicationTitle>Gastroenterology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/eff065f51ca67691f850c9769ae7f633"><gtr:id>eff065f51ca67691f850c9769ae7f633</gtr:id><gtr:otherNames>Clemons NJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0016-5085</gtr:issn><gtr:outcomeId>2AF54B22789</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0CCDEC25-1A7E-42BE-A4D5-9D18AF7CEBB5</gtr:id><gtr:title>Barrett's esophagus and cancer risk: how research advances can impact clinical practice.</gtr:title><gtr:parentPublicationTitle>Gut and liver</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/373e5f2601312795ff85b771b27a9a1a"><gtr:id>373e5f2601312795ff85b771b27a9a1a</gtr:id><gtr:otherNames>di Pietro M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1976-2283</gtr:issn><gtr:outcomeId>5436a4761acb29.58324697</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9EE394E3-CC60-4A7C-B31B-94D8DDBBCB6B</gtr:id><gtr:title>A genome-wide association study identifies new susceptibility loci for esophageal adenocarcinoma and Barrett's esophagus.</gtr:title><gtr:parentPublicationTitle>Nature genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3fce865c0ad059eea2fa17fdec7e9943"><gtr:id>3fce865c0ad059eea2fa17fdec7e9943</gtr:id><gtr:otherNames>Levine DM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1061-4036</gtr:issn><gtr:outcomeId>pm_13321_21_24121790</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BBCC688F-1E99-49AF-9A1B-C676829677E0</gtr:id><gtr:title>Epigenetic changes wipe out protective mechanisms in Barrett's oesophagus.</gtr:title><gtr:parentPublicationTitle>Gut</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f294d8b5abbe524be5d408e57d9b56ec"><gtr:id>f294d8b5abbe524be5d408e57d9b56ec</gtr:id><gtr:otherNames>Fitzgerald RC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0017-5749</gtr:issn><gtr:outcomeId>F04700EFEF1</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0E287A82-1AA7-4DE4-98DF-E35FD807E35E</gtr:id><gtr:title>Genetic predisposition to gastro-oesophageal cancer.</gtr:title><gtr:parentPublicationTitle>Current opinion in genetics &amp; development</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e1f129ca0f3f3de3bd6850d65b2b2bde"><gtr:id>e1f129ca0f3f3de3bd6850d65b2b2bde</gtr:id><gtr:otherNames>Lao-Sirieix P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0959-437X</gtr:issn><gtr:outcomeId>Nrxr74jQ94r</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0C67DFD2-8367-4237-8740-5CB5F9B7153C</gtr:id><gtr:title>A 4-gene signature predicts survival of patients with resected adenocarcinoma of the esophagus, junction, and gastric cardia.</gtr:title><gtr:parentPublicationTitle>Gastroenterology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/78d0a073824302dedfdd350ef449fe29"><gtr:id>78d0a073824302dedfdd350ef449fe29</gtr:id><gtr:otherNames>Peters CJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0016-5085</gtr:issn><gtr:outcomeId>ravExgZcDGe</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>07B7979D-2ACC-486F-9B06-3C70B9D1C641</gtr:id><gtr:title>Nitric oxide-mediated invasion in Barrett's high-grade dysplasia and adenocarcinoma.</gtr:title><gtr:parentPublicationTitle>Carcinogenesis</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/eff065f51ca67691f850c9769ae7f633"><gtr:id>eff065f51ca67691f850c9769ae7f633</gtr:id><gtr:otherNames>Clemons NJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0143-3334</gtr:issn><gtr:outcomeId>KWcZJpmhRRa</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>170CA54E-0EF1-4574-946C-AAFA96CE5994</gtr:id><gtr:title>A novel role for the retinoic acid-catabolizing enzyme CYP26A1 in Barrett's associated adenocarcinoma.</gtr:title><gtr:parentPublicationTitle>Oncogene</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/066d29ad97b024c2a8ff7b1a2a2e0ede"><gtr:id>066d29ad97b024c2a8ff7b1a2a2e0ede</gtr:id><gtr:otherNames>Chang CL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0950-9232</gtr:issn><gtr:outcomeId>56BE3B8CE7C</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D9696A91-2103-48C8-957C-3DEBB74157ED</gtr:id><gtr:title>Diagnosis and treatment of Barrett's oesophagus.</gtr:title><gtr:parentPublicationTitle>British medical bulletin</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/de14b639cc54247b2d3e4035c7848c9b"><gtr:id>de14b639cc54247b2d3e4035c7848c9b</gtr:id><gtr:otherNames>Lim YC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0007-1420</gtr:issn><gtr:outcomeId>pm_13321_21_23926313</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4E8EE6F7-201C-4FCD-B6F4-874A9865E898</gtr:id><gtr:title>Clinical puzzle: Barrett's oesophagus.</gtr:title><gtr:parentPublicationTitle>Disease models &amp; mechanisms</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/373e5f2601312795ff85b771b27a9a1a"><gtr:id>373e5f2601312795ff85b771b27a9a1a</gtr:id><gtr:otherNames>di Pietro M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1754-8403</gtr:issn><gtr:outcomeId>661B7B14BB2</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A54D847A-FF34-4E77-A5DE-F5272F011AD5</gtr:id><gtr:title>Familial gastric cancer - aetiology and pathogenesis.</gtr:title><gtr:parentPublicationTitle>Best practice &amp; research. Clinical gastroenterology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6a7678d5f58c189c745f4c120fbbaf7b"><gtr:id>6a7678d5f58c189c745f4c120fbbaf7b</gtr:id><gtr:otherNames>Barber M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>1521-6918</gtr:issn><gtr:outcomeId>3C50D310F03</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>63A0D841-DCC5-49BC-8DC4-8F3622DACD59</gtr:id><gtr:title>Cellular mechanisms of Barrett's esophagus development.</gtr:title><gtr:parentPublicationTitle>Surgical oncology clinics of North America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9b4df2be14a0c62d43a892f34bb17150"><gtr:id>9b4df2be14a0c62d43a892f34bb17150</gtr:id><gtr:otherNames>Barbera M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1055-3207</gtr:issn><gtr:outcomeId>C9E0299DC4D</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D8C13CB4-68F2-4166-990B-A589CE6E8B54</gtr:id><gtr:title>Impaired transforming growth factor beta signalling in Barrett's carcinogenesis due to frequent SMAD4 inactivation.</gtr:title><gtr:parentPublicationTitle>Gut</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/35d77a3d75be80d62942d0643d31ff40"><gtr:id>35d77a3d75be80d62942d0643d31ff40</gtr:id><gtr:otherNames>Onwuegbusi BA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0017-5749</gtr:issn><gtr:outcomeId>303750B9FB0</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">MC_U105365007</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>7C58A707-1BF6-4573-A44F-30B271C80813</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Cancer</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>34</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>89AE580F-2437-4540-9640-37005C968E67</gtr:id><gtr:percentage>33</gtr:percentage><gtr:text>4.1  Discovery and preclinical testing of markers and technologies</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>3BEA012A-C817-4067-8BE1-05331EBB5152</gtr:id><gtr:percentage>33</gtr:percentage><gtr:text>4.2  Evaluation of markers and technologies</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>